Response from CCIC Zhonghuan Certified Public Accountants to the inquiry letter on An Xu Biotech's 2023 report

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.